Biostim, Inc. – Trademark Portfolio

Entity Type: 03

Biostim, Inc. holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 7 filings in this category. The portfolio also extends into Class 37 (Building & Construction) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include BIOSTIM. The owner is based in Princeton, NJ.

Clarksville Rd. and Everette Dr.

Princeton, NJ 08540

8 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

BIOSTIM
BIOSTIM
Registered 1994
X-10
X-10
Cancelled 1984
BIOSTIM
BIOSTIM
Cancelled 1982
BIOEAR
BIOEAR
Cancelled 1982
B
B
Cancelled 1982

Trademark Classifications

Biostim, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (7 filings)

Surgical, medical, dental and veterinary apparatus and instruments

37
Building & Construction (1 filing)

Building construction; repair; installation services

Frequently Asked Questions

How many trademarks does Biostim, Inc. have?

Biostim, Inc. has 8 U.S. trademarks filed with the USPTO. Of these, 1 registered, 7 cancelled.

What trademark classes does Biostim, Inc. file in?

Biostim, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 37 (Building & Construction). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Biostim, Inc.'s most well-known trademarks?

Biostim, Inc.'s registered trademark portfolio includes well-known marks such as BIOSTIM. These are among 1 currently registered trademark in the portfolio.

What is Biostim, Inc.'s trademark registration success rate?

Biostim, Inc. has a 13% trademark registration rate, with 1 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.